Baseline risk stratification or duration of prior therapy predicts prognosis in patients with metastatic renal cell carcinoma treated with axitinib

Ryuichi Mizuno, Shuji Mikami, Kimiharu Takamatsu, Toshiaki Shinojima, Eiji Kikuchi, Mototsugu Oya

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Baseline risk stratification or duration of prior therapy predicts prognosis in patients with metastatic renal cell carcinoma treated with axitinib'. Together they form a unique fingerprint.

Medicine & Life Sciences